Bionomics Ltd. ADR (BNOX) concluded trading on Thursday at a closing price of $0.83, with 20.59 million shares of worth about $17.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.42% during that period and on July 18, 2024 the price saw a loss of about -1.12%. Currently the company’s common shares owned by public are about 8.16M shares, out of which, 8.15M shares are available for trading.
Stock saw a price change of 25.62% in past 5 days and over the past one month there was a price change of 4.69%. Year-to-date (YTD), BNOX shares are showing a performance of -43.92% which decreased to -68.62% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.65 but also hit the highest price of $6.41 during that period. The average intraday trading volume for Bionomics Ltd. ADR shares is 180.14K. The stock is currently trading 12.83% above its 20-day simple moving average (SMA20), while that difference is up 0.39% for SMA50 and it goes to -41.82% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bionomics Ltd. ADR (NASDAQ: BNOX) currently have 8.16M outstanding shares and institutions hold larger chunk of about 11.07% of that.
The stock has a current market capitalization of $8.87M and its 3Y-monthly beta is at -0.08. It has posted earnings per share of -$2.35 in the same period. It has Quick Ratio of 4.87 while making debt-to-equity ratio of 0.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BNOX, volatility over the week remained 15.17% while standing at 10.85% over the month.
Stock’s fiscal year EPS is expected to rise by 18.53% while it is estimated to increase by 27.94% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on September 28, 2023 offering a Buy rating for the stock and assigned a target price of $8 to it. Coverage by Maxim Group stated Bionomics Ltd. ADR (BNOX) stock as a Buy in their note to investors on September 28, 2023, suggesting a price target of $10 for the stock. On January 10, 2022, H.C. Wainwright Initiated their recommendations, while on January 10, 2022, Evercore ISI Initiated their ratings for the stock with a price target of $17. Stock get an Overweight rating from Cantor Fitzgerald on January 10, 2022.
